Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 USD | +1.62% | +4.38% | -40.21% |
31/01 | Transcript : Regis Corporation, Q2 2024 Earnings Call, Jan 31, 2024 | |
31/01 | Regis Corporation Provides Strategic Review Update | CI |
Sales 2022 | 276M 23.01B | Sales 2023 | 233M 19.45B | Capitalization | 50.58M 4.22B |
---|---|---|---|---|---|
Net income 2022 | -85M -7.09B | Net income 2023 | -7M -584M | EV / Sales 2022 | 2.62 x |
Net Debt 2022 | 675M 56.25B | Net Debt 2023 | 541M 45.12B | EV / Sales 2023 | 2.54 x |
P/E ratio 2022 |
-0.38
x | P/E ratio 2023 |
-6.95
x | Employees | 397 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.58% |
Latest transcript on Regis Corporation
1 day | +1.62% | ||
1 week | +4.38% | ||
Current month | -24.67% | ||
1 month | -20.42% | ||
3 months | -58.91% | ||
6 months | -51.31% | ||
Current year | -40.21% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Doctor
CEO | Chief Executive Officer | 37 | 01/21/01 |
Kersten Zupfer
DFI | Director of Finance/CFO | 49 | 01/07/01 |
Jim Lain
COO | Chief Operating Officer | 60 | 11/13/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Mansbach
BRD | Director/Board Member | 56 | 14/21/14 |
Margaret Rhoades
BRD | Director/Board Member | 79 | 20/15/20 |
Michael Merriman
BRD | Director/Board Member | 67 | 27/11/27 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 5.65 | +1.62% | 12,111 |
25/24/25 | 5.56 | +0.18% | 15,993 |
24/24/24 | 5.55 | +1.83% | 21,201 |
23/24/23 | 5.45 | 0.00% | 17,531 |
22/24/22 | 5.45 | +0.68% | 27,511 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-40.21% | 12.88M | |
-14.20% | 567M | |
+41.52% | 472M | |
+9.91% | 294M | |
-22.99% | 203M | |
-25.53% | 93.09M | |
-4.20% | 80.02M | |
-10.34% | 66.43M | |
-19.67% | 66.28M | |
0.00% | 61.81M |
- Stock Market
- Equities
- RGS Stock